HMGB1 and Cognitive impairment: Anti-HMGB1 mAb has ameliorated the symptoms and phenotype of AD in an experimental model where mAb against HMGB1 completely rescued cognitive impairment in a mouse model via inhibiting neurite degeneration even in the presence of amyloid beta (Aβ) plaques.